MAP.AU MICROBA LIFE SCIENCES LTD
Not Yet Opened 11-07 16:12:00 AEDT
0.17
+0.00
-2.94%
High
0.17
Low
0.17
Vol
117.19K
Open
0.17
D1 Closing
0.17
Amplitude
2.94%
Mkt Cap
73.90M
Tradable Cap
32.58M
Total Shares
447.85M
T/O
19.70K
T/O Rate
0.06%
Tradable Shares
197.48M
P/B
--
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
News
New Post(s)
Profile
BRIEF-Microba Life Sciences Posts Qtrly Revenue A$3.65M
Reuters · 10-29
BRIEF-Microba Life Sciences Posts Qtrly Revenue A$3.65M
Microba Life Sciences Ltd - Qtrly Revenue of a$3.65M
THOMSON REUTERS · 10-29
Microba Life Sciences Ltd - Qtrly Revenue of a$3.65M
Analysts Expect Breakeven For Microba Life Sciences Limited (ASX:MAP) Before Long
Simply Wall St. · 10-11
Analysts Expect Breakeven For Microba Life Sciences Limited (ASX:MAP) Before Long
Microba Life Sciences Agrees to Transfer Research Services Business to Clinical Microbiomics
MT Newswires Live · 10-11
Microba Life Sciences Agrees to Transfer Research Services Business to Clinical Microbiomics
BRIEF-Microba Life Sciences Announces Transfer Of Microba Research Services Unit To CMC
Reuters · 10-10
BRIEF-Microba Life Sciences Announces Transfer Of Microba Research Services Unit To CMC
Microba Life Sciences Ltd - Strategic Transfer of Microba Research Services Unit to Cmc
THOMSON REUTERS · 10-10
Microba Life Sciences Ltd - Strategic Transfer of Microba Research Services Unit to Cmc
Microba Life Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. · 08-31
Microba Life Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
BUZZ-Australia's Microba Life Sciences falls as annual loss widens
Reuters · 08-29
BUZZ-Australia's Microba Life Sciences falls as annual loss widens
BRIEF-Microba Life Sciences Says Loss For Year Attributable A$19.9 Million
Reuters · 08-29
BRIEF-Microba Life Sciences Says Loss For Year Attributable A$19.9 Million
BRIEF-Microba Life Sciences Posts A$4.81 Mln Q4 Fy24 Unaudited Revenue
Reuters · 07-25
BRIEF-Microba Life Sciences Posts A$4.81 Mln Q4 Fy24 Unaudited Revenue
Microba Life Sciences - a$4.81M in Q4 FY24 Unaudited Revenue, up 20.2% Qoq
THOMSON REUTERS · 07-25
Microba Life Sciences - a$4.81M in Q4 FY24 Unaudited Revenue, up 20.2% Qoq
Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%
MT Newswires Live · 06-28
Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%
Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%
MT Newswires Live · 06-28
Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%
Insiders Give Up AU$119k As Microba Life Sciences Stock Drops To AU$0.18
Simply Wall St. · 06-07
Insiders Give Up AU$119k As Microba Life Sciences Stock Drops To AU$0.18
Load more
Introduction
Company Name.
MICROBA LIFE SCIENCES LTD
Affiliated Markets:
ASX
Listing Date:
--
Main Business:
Issue price:
--
{"stockData":{"symbol":"MAP.AU","market":"AU","secType":"STK","nameCN":"MICROBA LIFE SCIENCES LTD","latestPrice":0.165,"timestamp":1730956320000,"preClose":0.17,"halted":0,"volume":117185,"delay":0,"nameEN":"MICROBA LIFE SCIENCES LTD","floatShares":197475358,"shares":447851977,"eps":-0.048647,"marketStatus":"Not Yet Opened","change":-0.005,"latestTime":"11-07 16:12:00 AEDT","open":0.17,"high":0.17,"low":0.165,"amount":19701,"amplitude":0.029412,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.048647,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1731020400000},"marketStatusCode":0,"adr":0,"listingDate":1648994400000,"exchange":"ASX","adjPreClose":0.17,"openAndCloseTimeList":[[1730934000000,1730955600000]],"volumeRatio":0.8964265330637304,"lotSize":0,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/MAP.AU","defaultTab":"news","newsList":[{"id":"2479992784","title":"BRIEF-Microba Life Sciences Posts Qtrly Revenue A$3.65M","url":"https://stock-news.laohu8.com/highlight/detail?id=2479992784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479992784?lang=en_us&edition=fundamental","pubTime":"2024-10-29 09:22","pubTimestamp":1730164973,"startTime":"0","endTime":"0","summary":"Oct 29 (Reuters) - Microba Life Sciences Ltd : * QTRLY REVENUE OF A$3.65MSource text: Further company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU"],"gpt_icon":0},{"id":"2479469907","title":"Microba Life Sciences Ltd - Qtrly Revenue of a$3.65M","url":"https://stock-news.laohu8.com/highlight/detail?id=2479469907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479469907?lang=en_us&edition=fundamental","pubTime":"2024-10-29 06:15","pubTimestamp":1730153741,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241028:nFWN3M41VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2474702455","title":"Analysts Expect Breakeven For Microba Life Sciences Limited (ASX:MAP) Before Long","url":"https://stock-news.laohu8.com/highlight/detail?id=2474702455","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474702455?lang=en_us&edition=fundamental","pubTime":"2024-10-11 07:52","pubTimestamp":1728604334,"startTime":"0","endTime":"0","summary":"Microba Life Sciences Limited is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. The AU$78m market-cap company announced a latest loss of AU$20m on 30 June 2024 for its most recent financial year result. As path to profitability is the topic on Microba Life Sciences' investors mind, we've decided to gauge market sentiment. We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.View our latest analysis for Microba Life Sciences. Working backwards from analyst estimates, it turns out that they expect the company to grow 45% year-on-year, on average, which is extremely buoyant. Should the business grow at a slower rate, it will become pro","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/analysts-expect-breakeven-microba-life-235214462.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2474709840","title":"Microba Life Sciences Agrees to Transfer Research Services Business to Clinical Microbiomics","url":"https://stock-news.laohu8.com/highlight/detail?id=2474709840","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474709840?lang=en_us&edition=fundamental","pubTime":"2024-10-11 06:56","pubTimestamp":1728601017,"startTime":"0","endTime":"0","summary":"Microba Life Sciences agreed to transfer its non-core research services business to Denmark-headquartered microbiome genetic company Clinical Microbiomics, according to a Thursday filing with the Australian bourse.The business registered AU$2.6 million in revenue in fiscal 2024 and operated on a cashflow breakeven basis.Under the terms, the biotech company will retain its intellectual property and provide Clinical Microbiomics with certain transitional services for a fee.Microba expects to receive up to AU$3 million in potential revenue over the next four years as a result of the transfer, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2474735537","title":"BRIEF-Microba Life Sciences Announces Transfer Of Microba Research Services Unit To CMC","url":"https://stock-news.laohu8.com/highlight/detail?id=2474735537","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474735537?lang=en_us&edition=fundamental","pubTime":"2024-10-10 09:12","pubTimestamp":1728522730,"startTime":"0","endTime":"0","summary":"Oct 10 (Reuters) - Microba Life Sciences Ltd : * STRATEGIC TRANSFER OF MICROBA RESEARCH SERVICES UNIT TO CMC * TRANSFER OF ITS NON-CORE RESEARCH SERVICES BUSINESS UNIT TO CLINICAL MICROBIOMICS Further company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU","BK7124"],"gpt_icon":0},{"id":"2474378375","title":"Microba Life Sciences Ltd - Strategic Transfer of Microba Research Services Unit to Cmc","url":"https://stock-news.laohu8.com/highlight/detail?id=2474378375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474378375?lang=en_us&edition=fundamental","pubTime":"2024-10-10 06:10","pubTimestamp":1728511822,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241009:nFWN3LL110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2463794683","title":"Microba Life Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2463794683","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463794683?lang=en_us&edition=fundamental","pubTime":"2024-08-31 04:13","pubTimestamp":1725048830,"startTime":"0","endTime":"0","summary":"ASX:MAP Earnings and Revenue Growth August 30th 2024. All figures shown in the chart above are for the trailing 12 month period. Revenue exceeded analyst estimates by 1.2%. Earnings per share missed analyst estimates by 13%.Looking ahead, revenue is forecast to grow 39% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Healthcare industry in Australia.The company's shares are down 5.3% from a week ago.You should always think about risks. Case in point, we've spotted 4 warning signs for Microba Life Sciences you should be aware of, and 1 of them is a bit unpleasant.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/microba-life-sciences-full-2024-201350476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MAP.AU"],"gpt_icon":0},{"id":"2463947614","title":"BUZZ-Australia's Microba Life Sciences falls as annual loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2463947614","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463947614?lang=en_us&edition=fundamental","pubTime":"2024-08-29 12:26","pubTimestamp":1724905586,"startTime":"0","endTime":"0","summary":"** Shares of Microba Life Sciences fall as much as 10.8% to A$0.165, set for worst day since July 11, if current losses hold ** Health sciences co says its annual loss after income tax attributab","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAO.AU","XKO.AU","BK7124","MAP.AU","XJO.AU"],"gpt_icon":0},{"id":"2463423714","title":"BRIEF-Microba Life Sciences Says Loss For Year Attributable A$19.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2463423714","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463423714?lang=en_us&edition=fundamental","pubTime":"2024-08-29 09:31","pubTimestamp":1724895062,"startTime":"0","endTime":"0","summary":"Aug 29 (Reuters) - Microba Life Sciences Ltd : * LOSS FOR YEAR ATTRIBUTABLE A$19.9 MILLION * FY REVENUES FROM ORDINARY ACTIVITIES A$12.1 MILLION Further company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2454895836","title":"BRIEF-Microba Life Sciences Posts A$4.81 Mln Q4 Fy24 Unaudited Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2454895836","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454895836?lang=en_us&edition=fundamental","pubTime":"2024-07-25 10:45","pubTimestamp":1721875532,"startTime":"0","endTime":"0","summary":"July 25 (Reuters) - Microba Life Sciences Ltd : * A$4.81M IN Q4 FY24 UNAUDITED REVENUE, UP 20.2% QOQFurther company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU"],"gpt_icon":0},{"id":"2454577708","title":"Microba Life Sciences - a$4.81M in Q4 FY24 Unaudited Revenue, up 20.2% Qoq","url":"https://stock-news.laohu8.com/highlight/detail?id=2454577708","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454577708?lang=en_us&edition=fundamental","pubTime":"2024-07-25 07:04","pubTimestamp":1721862296,"startTime":"0","endTime":"0","summary":"Microba Life Sciences - a$4.81M in Q4 FY24 Unaudited Revenue, up 20.2% Qoq","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240724:nFWN3JG257:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2446548977","title":"Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446548977","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446548977?lang=en_us&edition=fundamental","pubTime":"2024-06-28 11:01","pubTimestamp":1719543712,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK7124","BK4125","XKO.AU","XAO.AU","AUD","MAP.AU","XJO.AU"],"gpt_icon":0},{"id":"2446548903","title":"Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446548903","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446548903?lang=en_us&edition=fundamental","pubTime":"2024-06-28 11:01","pubTimestamp":1719543712,"startTime":"0","endTime":"0","summary":"Microba Life Sciences completed screening activities for its autoimmune disease therapeutic discovery program in partnership with Ginkgo Bioworks, according to a Friday filing with the Australian Securities Exchange.Under the program, six therapeutic leads with strong disease-relevant activity have been chosen for further preclinical development. Leads with strong immunomodulatory effects in a variety of disease-relevant cell types were found through the screening, the filing said.The program's next phases include evaluating the therapeutic efficacy of the lead strains in disease-relevant animal models and manufacturing for clinical trials, the company said.Shares fell 3% in midday trading.Price : $0.16, Change: $-0.01, Percent Change: -3.03%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AUD","BK7124","MAP.AU","BK4125"],"gpt_icon":0},{"id":"2441577458","title":"Insiders Give Up AU$119k As Microba Life Sciences Stock Drops To AU$0.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2441577458","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441577458?lang=en_us&edition=fundamental","pubTime":"2024-06-07 04:49","pubTimestamp":1717706996,"startTime":"0","endTime":"0","summary":"The recent 10.0% drop in Microba Life Sciences Limited's ( ASX:MAP ) stock could come as a blow to insiders who...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-map/microba-life-sciences-shares/news/insiders-give-up-au119k-as-microba-life-sciences-stock-drops","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MAP.AU","BK7124"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.microba.com","stockEarnings":[{"period":"1week","weight":-0.0678},{"period":"1month","weight":-0.0833},{"period":"3month","weight":-0.0833},{"period":"6month","weight":-0.0571},{"period":"1year","weight":-0.2143},{"period":"ytd","weight":-0.0833}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":-0.009},{"period":"3month","weight":0.0202},{"period":"6month","weight":0.0152},{"period":"1year","weight":0.1652},{"period":"ytd","weight":0.1327}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"exchange":"ASX","name":"MICROBA LIFE SCIENCES LTD","nameEN":"MICROBA LIFE SCIENCES LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MICROBA LIFE SCIENCES LTD(MAP.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MICROBA LIFE SCIENCES LTD(MAP.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MICROBA LIFE SCIENCES LTD,MAP.AU,MICROBA LIFE SCIENCES LTD股票,MICROBA LIFE SCIENCES LTD股票老虎,MICROBA LIFE SCIENCES LTD股票老虎国际,MICROBA LIFE SCIENCES LTD行情,MICROBA LIFE SCIENCES LTD股票行情,MICROBA LIFE SCIENCES LTD股价,MICROBA LIFE SCIENCES LTD股市,MICROBA LIFE SCIENCES LTD股票价格,MICROBA LIFE SCIENCES LTD股票交易,MICROBA LIFE SCIENCES LTD股票购买,MICROBA LIFE SCIENCES LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MICROBA LIFE SCIENCES LTD(MAP.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MICROBA LIFE SCIENCES LTD(MAP.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}